Meeting
2014 ASCO Annual Meeting
The effects of omega-3 fatty acids on chemotherapy-induced neuropathy and inflammation in patients with breast cancer.
Authors
Ali Esfahani
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Tabriz, Iran
Ali Esfahani , Zohreh Ghoreishi , Bina Eftekharsadat , Mohammad Asghari Jafarabadi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Clinical Trial Registration Number
NCT01049295
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1039)
DOI
10.1200/jco.2014.32.15_suppl.1039
Abstract #
1039
Poster Bd #
132
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Pharmacological cardioprotective strategy for non-metastatic patients affected by breast cancer receiving an anthracycline-based chemotherapy: Final results of the phase 3 SAFE trial.
First Author: Lorenzo Livi
Poster
2022 ASCO Annual Meeting
Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin versus placebo in hormone receptor–positive early-stage breast cancer (CCTG MA32).
First Author: Dawn L. Hershman
Poster
2024 ASCO Annual Meeting
A meta-analysis GWAS of taxane-induced peripheral neuropathy in patients with breast cancer.
First Author: Yuanchu James Yang
Poster
2023 ASCO Breakthrough
Topical diclofenac in prevention of capecitabine associated HFS in patients with breast cancer: An exploratory subgroup analysis of the D-ToRCH study.
First Author: AKHIL SANTHOSH